From nursing homes in New York and a landfill in Utah to Disney World and the Las Vegas Strip, employers are wrestling with workplace safety in the age of Covid-19 and making fraught calculations about how to safeguard both their businesses and their employees.
Mass testing, a critical tool to stem the virus’s spread, would appear an obvious solution.
But dogged by issues of cost — diagnostic tests start at around $100 each — access, logistics and employee privacy, tests aren’t part of most back-to-work plans. As health-care companies that work with employers in this capacity are fond of saying, there’s no silver bullet.
Another major deterrent is ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.